← Back to All Insights

Financial Services & Healthcare

Governance where consequences matter

Explore control and evidence questions in Piscys’ initial focus industries, with equal attention to financial services and healthcare.

Different workflows and obligations. A shared need for bounded authority, qualified review, and defensible decisions.

Clinical and financial signal patterns converging through a shared governance control point.

Selected sources with Piscys commentary. External publications remain the work of their respective authors.

01 / Financial Services

Trace the Decision. Define the Authority.

Connect institution-level risk concerns with the evidence and human review needed inside a consequential financial workflow.

Bank of England · September 30, 2026

Systemic Risk Survey · 2026 H2

AI Risk in The Financial System

The latest survey records a substantial increase in financial-sector respondents identifying AI as a source of systemic risk.

Piscys Lens

Use the findings to sharpen board-level questions about control gaps and ownership. These are risk perceptions, not measured incident rates.

Read original →

OpenAI Cookbook · July 2026

Technical Demonstration

Evidence-Grounded AML Analysis

A synthetic anti-money-laundering example linking findings to evidence, validating calculations, and routing work for qualified review.

Piscys Lens

Separate analysis, authorization to draft, and filing decisions. Demonstration rules are not regulatory thresholds or proof of production compliance.

Read original →

02 / Healthcare

Preserve Evidence Through Change

Consider policy provenance, review routing, and controlled changes while keeping clinical, payer, and device contexts distinct.

CMS · January 2024

Final Rule

Prior Authorization As an Evidence and Accountability Workflow

CMS requires impacted payers to strengthen prior authorization processes, including faster decisions, denial reasons, public metrics, and new FHIR-based APIs.

Piscys Lens

Faster authorization requires more than faster processing. Organizations should govern policy provenance, decision authority, supporting evidence, and exception handling.

Read original →

CMS · April 2026

Proposed Rule

Prior Authorization Controls Face an Expanding Regulatory Scope

CMS proposes extending electronic prior authorization requirements to drugs, alongside updated standards, decision timeframes, and API reporting requirements.

Piscys Lens

As authorization scope expands, enterprises should preserve consistent policy retrieval, review authority, evidence retention, and exception handling across changing workflows.

Read original →

OpenAI Cookbook · August 2026

Technical Demonstration

Evidence and Review in Prior Authorization

An example connecting policy retrieval, supporting evidence, citation validation, and review routing using the Agents SDK and Amazon Bedrock AgentCore.

Piscys Lens

Inspect who controls policy versions and review routing. The example uses a synthetic member and sample payer.

Read original →

FDA · August 2025

Final Guidance

Change Control for AI-Enabled Medical Devices

Recommendations for describing planned device changes, methods for developing and validating them, and their potential impact.

Piscys Lens

Know which changes are within the authorized plan and what evidence supports them. Scope is applicable AI-enabled devices, not all healthcare AI.

Read original →

From Insight to Action

Start with One Consequential Workflow

Discuss where AI influences decisions in your environment, who owns the outcome, and what evidence would support responsible deployment.

Request an Executive Briefing

Advisory services are available now. The Piscys software platform is in development.